What is the appropriate workup for Guillain-Barré syndrome?

Workup for Guillain-Barré Syndrome

The workup for Guillain-Barré syndrome requires three core investigations: CSF examination showing albumino-cytological dissociation, electrodiagnostic studies to confirm peripheral nerve dysfunction, and basic laboratory tests to exclude mimics—all performed urgently while not delaying treatment if clinical suspicion is high 1.

Clinical Recognition First

Suspect GBS when you see rapidly progressive bilateral limb weakness (typically ascending from legs to arms) with decreased or absent reflexes, developing over days to 4 weeks (usually <2 weeks). Key clinical features that strengthen the diagnosis include 1:

• Preceding infection in the 6 weeks before symptom onset (reported in two-thirds of patients)
• Bilateral facial palsy or other cranial nerve involvement
• Dysautonomia (blood pressure/heart rate instability, pupillary dysfunction)
• Pain (muscular, radicular, or neuropathic)—can precede weakness and cause diagnostic confusion
• Relative symmetry of weakness, though some asymmetry is acceptable

Critical Timing Pitfall

If maximum disability occurs within 24 hours or after 4 weeks, strongly reconsider alternative diagnoses 1.

Essential Laboratory Workup

1. Cerebrospinal Fluid Examination (Perform Immediately)

CSF analysis is mandatory during initial evaluation to rule out alternative diagnoses and support GBS 1:

• Classic finding: Elevated protein with normal cell count (albumino-cytological dissociation)
• Critical caveat: Protein is normal in 30-50% of patients in week 1 and 10-30% in week 2—normal CSF protein does NOT rule out GBS 1
• Red flags suggesting alternative diagnosis:
  • Marked pleocytosis (>50 cells/μl): Consider leptomeningeal malignancy, infectious/inflammatory myelitis or polyradiculitis
  • Mild pleocytosis (10-50 cells/μl): Still compatible with GBS but warrants investigation for infectious polyradiculitis 1

2. Basic Blood Tests (All Patients)

Obtain complete blood count and tests for glucose, electrolytes, kidney function, and liver enzymes to exclude metabolic causes, electrolyte disturbances, and infections that mimic acute flaccid paralysis 1.

3. Anti-Ganglioside Antibody Testing (Limited Value)

Do not wait for antibody results before starting treatment 1:

• Limited diagnostic utility in typical sensorimotor GBS—positive results help when diagnosis is uncertain, but negative results don't exclude GBS 1
• Exception: Anti-GQ1b antibodies have high diagnostic value (positive in up to 90% of Miller Fisher syndrome cases) and should be tested when MFS is suspected 1
• Testing is assay-dependent and results vary in reliability 1

4. Electrodiagnostic Studies (Recommended but Not Required)

Nerve conduction studies support the diagnosis but are not mandatory to start treatment 1:

• Perform wherever possible, especially in atypical presentations 1
• Expected findings: Sensorimotor polyradiculoneuropathy with reduced conduction velocities, reduced amplitudes, temporal dispersion, or conduction blocks
• Classic pattern: "Sural sparing" (normal sural sensory potential while median/ulnar sensory potentials are abnormal/absent) 1

Important limitations 1:

• May be normal in the first week or with proximal weakness, mild disease, or certain variants
• If initial study is normal but clinical suspicion remains high, repeat in 2-3 weeks 1
• In Miller Fisher syndrome, studies are usually normal or show only reduced sensory amplitudes 1

Algorithmic Approach to Workup

1. Recognize clinical pattern: Bilateral ascending weakness + areflexia + progression over days to <4 weeks
2. Perform CSF examination immediately: Look for albumino-cytological dissociation (but remember normal protein doesn't exclude GBS early on)
3. Order basic labs: CBC, glucose, electrolytes, renal/hepatic function to exclude mimics
4. Arrange electrodiagnostic studies: Support diagnosis and classify subtype, but don't delay treatment
5. Consider anti-GQ1b antibodies: Only if Miller Fisher syndrome suspected
6. Start treatment promptly: Don't wait for antibody results or repeat electrophysiology 1

Key Diagnostic Pitfalls to Avoid

• Don't dismiss GBS with normal CSF protein in week 1-2 1
• Don't rely on anti-ganglioside antibodies for typical GBS diagnosis 1
• Don't delay treatment waiting for electrodiagnostic confirmation 1
• Reconsider diagnosis if progression continues beyond 8 weeks—approximately 5% initially diagnosed with GBS actually have acute-onset CIDP (A-CIDP) 2
• Watch for atypical presentations in young children: nonspecific pain, refusal to walk, irritability, meningism 1